IP Verse

Targeted Rna Editing

Patent No. EP3234134 (titled "Targeted Rna Editing") was filed by Proqr Therapeutics II on Dec 17, 2015. The application was issued on May 27, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONFeb 25, 2021MAIWALD
STRAWMANFeb 25, 2021LEONARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3234134

PROQR THERAPEUTICS II
Application Number
EP15813826A
Filing Date
Dec 17, 2015
Status
Granted And Under Opposition
Apr 24, 2020
Publication Date
May 27, 2020
External Links
Slate, Register , Google Patents